ArticleMolecular therapy. Nucleic acids2026
An acyclic nucleic acid-modified siRNA targeting CAG expansions for polyglutamine disease treatment.
Kentaro Maeda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it